Behavioral Prevention, Treatment, and Rehabilitation of Using Western and Chinese Medicines or Herbal Products among the Public in Response to COVID-19 in Hong Kong: A Cross-Sectional Study

Table 2

Chinese medicines and Western medicines used for COVID-19 depend on gender.

	Prevention	Treatment	Rehabilitation	Row total
Chinese medicines
Male
Frequency (expected) (χ^2)	30 (29.6) (0.00)	53 (52.7) (0.00)	45 (45.7) (0.01)	128
Row (%)	23.4%	41.4%	35.2%	41.2%
Column (%)	41.7%	41.4%	40.5%
Female
Frequency (expected) (χ^2)	42 (42.4) (0.00)	75 (75.3) (0.00)	66 (65.3) (0.01)	183
Row (%)	23.0%	41.0%	36.1%	58.8%
Column (%)	58.3%	58.6%	59.5%
Column total	72	128	111	311
	23.2%	41.2%	35.7%	100%
Chi-square test	χ^2: 0.028			—
	DF: 2
	value: 0.986
Western medicines
Male
Frequency (expected) (χ^2)	37 (36.9) (0.00)	64 (58.0) (0.63)	5 (11.1) (3.37)	106
Row (%)	34.9%	60.4%	4.7%	39.7%
Column (%)	39.8%	43.8%	17.9%
Female
Frequency (expected) (χ^2)	56 (56.1) (0.00)	82 (88.0) (0.41)	23 (16.9) (2.22)	161
Row (%)	34.8%	50.9%	14.3%	60.3%
Column (%)	60.2%	56.2%	82.1%
Column total	93	146	28	267
	34.8%	54.7%	10.5%	100%
Chi-square test	χ^2: 6.624			—
	DF: 2
	value: 0.036